Subscribe or Manage Preferences
The first large study of pregnancy outcomes among women with childhood-onset systemic lupus erythematosus (cSLE) demonstrates a high incidence of stillbirths and spontaneous abortions. These data are similar in women with adult-onset SLE.
Although the risk for infection is twice as high in patients with autoimmune rheumatic arthritis (RA) compared with age- and gender-matched controls, vaccination rates among this patient population are consistently low, according to Diana S. Sandler, MD, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • FDA Approves Infliximab Biosimilar for Multiple Indications
  • Ixekizumab FDA Approved for Patients with Plaque Psoriasis
  • First Once-Daily, Oral JAK Inhibitor Approved for Patients with RA
Patients with fibromyalgia have access to a limited number of therapeutic options. One of 3 drugs approved for patients with fibromyalgia, pregabalin is an anticonvulsant and α-2-Δ subunit receptor ligand that has shown clinically meaningful benefits across multiple fibromyalgia symptom domains.
  • Rapid Access Rheumatology Consultations Feasible, Beneficial
  • Etanercept plus MTX More Cost-Effective than Monotherapy in Patients with Severe JIA
  • Higher Costs Linked to Lower DMARD Initiations, Refills in MAPD Members with RA
  • Higher Social Support Associated with Less Depression in Older Patients with RA
Recently, investigators demonstrated the feasibility of gathering data on several key gout treatment quality indicators from EMRs. Using 10 quality indicators for gout care established more than a dozen years ago, they found that although some quality indicators are easy to assess with EMRs, others are difficult.
In the United States, arthritis is a leading cause of disability, a common cause of chronic pain, and affects more than 1 in every 5 American adults. May is National Arthritis Awareness month, and rheumatologists, nurses, and other healthcare providers should take the opportunity of this campaign by helping their patients understand their condition, learn facts about arthritis, and gain access to relevant resources.
A retrospective chart review paints a glowing portrait of the effects of belimumab in patients with systemic lupus erythematosus (SLE). The biologic medication was associated with significant reduction in disease severity and glucocorticoid dose, according to the researchers.
A retrospective chart review paints a glowing portrait of the effects of belimumab in patients with systemic lupus erythematosus (SLE). The biologic medication was associated with significant reduction in disease severity and glucocorticoid dose, according to the researchers.
  • Growing Burden of Arthritis
  • Pregnancy Outcomes in Systemic Lupus Erythematosus
  • NSAIDs Safe for Axial Spondyloarthritis
  • Rheumatic Problems with Chikungunya
  • Seizures in Systemic Lupus Erythematosus
  • Link Between TNFi Therapy and Breast Cancer Not Found in New Study
  • Bipolar Disorder and Rheumatoid Arthritis Not Significantly Associated
  • International Team Drafts List of Infections Associated with Biologic Therapy for Inflammatory Conditions
Page 1 of 2
Results 1 - 10 of 17
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology